PRO-V COAT
K103514 · Bisco, Inc. · EBG · May 25, 2011 · Dental
Device Facts
| Record ID | K103514 |
| Device Name | PRO-V COAT |
| Applicant | Bisco, Inc. |
| Product Code | EBG · Dental |
| Decision Date | May 25, 2011 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3770 |
| Device Class | Class 2 |
Intended Use
Pro-V Coat is indicated for use as a separating agent when placed between any resin based material and to the substrate to which permanent bonding is not desired, such as: 1. any resin based material to the adhesive layer. 2. any resin based material to the remaining tooth structure.
Device Story
Pro-V Coat is a water-soluble dental separating agent. Applied by a clinician between resin-based temporary restorative materials and the underlying adhesive layer or tooth structure to prevent permanent bonding. The agent facilitates the easy removal of temporary restorations using hand instruments. Post-removal, the agent is rinsed away with water. It is designed for clean removal without residue and does not interfere with the subsequent adhesion of final restorations. Used in a clinical dental setting.
Clinical Evidence
Bench testing only. Laboratory R&D protocols compared physical and mechanical properties (viscosity, water solubility) and efficacy as a separating agent against the predicate device. Biocompatibility testing was conducted in accordance with ISO 10993-1, including cytotoxicity testing, to confirm safety.
Technological Characteristics
Water-soluble, low-viscosity liquid separating agent containing volatile solvents. Formulated for application between resin-based materials and tooth/adhesive substrates. Biocompatibility evaluated per ISO 10993-1.
Indications for Use
Indicated for use as a separating agent in dental procedures to prevent bonding between resin-based restorative materials and adhesive layers or remaining tooth structure.
Regulatory Classification
Identification
A temporary crown and bridge resin is a device composed of a material, such as polymethylmethacrylate, intended to make a temporary prosthesis, such as a crown or bridge, for use until a permanent restoration is fabricated.
Predicate Devices
Related Devices
- K073263 — PRO-V · Bisco, Inc. · Feb 14, 2008
- K973201 — PROVI CEMENT · S & C Polymer GmbH · Jun 5, 1998
- K162408 — Nano Varnish, Plaquit, Lightpaint on Surface · Dreve Dentamid GmbH · Apr 5, 2018
- K161630 — Provicol QM Plus · Voco GmbH · Sep 15, 2016
- K031212 — TEMPORARY RESIN CEMENT · Parkell, Inc. · Jul 11, 2003
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo for BISCO, a dental supply company. The logo consists of the letters "BISCO" arranged in a hexagonal pattern. Below the logo is the tagline "Bringing Science to the Art of Dentistry."
K103514
MAY 25 2011
# 510 (k) SUMMARY
| Applicant: | Bisco, Inc. |
|----------------------|----------------------------------|
| | 1100 W. Irving Park Road |
| | Schaumburg IL, 60193 |
| Contact Person: | Michelle Schiltz-Taing |
| | Tel: 847-534-6000 |
| | Fax: 847-534-6111 |
| Date Prepared: | 24 November 2010 |
| Trade Name: | Pro-V Coat |
| Common Name: | Separating Agent |
| Product Code: | EBG |
| Classification/Name: | Temporary Crown and Bridge Resin |
| | Class II per 21 CFR 872.3770 |
# Predicate Device:
Pro-V Coat is substantially equivalent to Pro-V by Bisco, Inc. Schaumburg IL K073263
# Indications for Use:
Pro-V Coat is indicated for use as a separating agent when placed between any resin based material and to the substrate to which permanent bonding is not desired, such as:
- 1. any resin based material to the adhesive layer.
- 2. any resin based material to the remaining tooth structure.
# Description of Applicant Device:
Pro-V Coat is a water soluble separating agent that effectively prohibits bonding of the resin-based material used for temporary restorations to the adhesive interface or to the remaining tooth structure. Pro-V Coat along with the temporary restoration will remain in place for a certain period of time. The temporary restorative material is easily removed with hand instruments and the Pro-V Coat is rinsed off with copious amounts of water. Pro-V Coat is designed to clean up effortlessly without any residue. Pro-V Coat will not compromise subsequent adhesion of the final restoration.
# Technological Characteristics
All components of Pro-V Coat are found in the legally marketed predicate device Pro-V K073263, (referenced in this submission as the predicate). A comparison of the chemical composition of Pro-V Coat to the predicate is provided in Table 1:
> BISCO, Inc. 1100 W. Irving Park Road Schaumburg, IL 60193 U.S.A.
800-247-3368 or 847-534-6000 Fax: 847-891-5049 www.bisco.com
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the logo for BISCO, a dental company. The logo consists of the letters "BISCO" in a stylized font, with each letter contained within a hexagon. Below the logo is the tagline "Bringing Science to the Art of Dentistry™".
# 510 (k) SUMMARY (Continued)
| Chemical Composition | Predicate | Pro-V Coat |
|---------------------------|-----------|------------|
| Water soluble | X | X |
| Contains volatile solvent | X | X |
# Performance Data:
The physical/mechanical properties of Pro-V Coat were tested in the lab using R&D testing protocols. The information provided in this 510(k) of Pro-V Coat compared to the predicate demonstrated that Pro-V Coat was an effective separating agent and that it inhibited bonding between the adhesive / tooth structure and the restorative material. A comparison of the physical/mechanical properties is included in Table 2.
# Table 2:
| Physical / Mechanical Property<br>Comparison | Predicate | Pro-V Coat |
|----------------------------------------------|-----------|------------|
| Low viscosity | X | X |
| Water soluble | X | X |
# Biocompatibility:
An evaluation of biocompatibility was conducted to determine the safety of the Pro-V Coat using FDA and internationally recognized guidelines ISO 10993-1. The conclusion of the safety evaluation and subsequent cytotoxicity testing is that Pro-V Coat is safe for its intended use.
# Conclusion:
Side by side comparisons clearly demonstrate that the applicant device is substantially equivalent to the other legally marketed device Pro-V K073263. It is concluded that the information supplied in this submission has proven the safety and efficacy of this product.
> BISCO, Inc. 1100 W. Irving Park Road Schaumburg, IL 60193 U.S.A.
800-247-3368 or 847-534-6000 Fax: 847-891-5049 www.bisco.com
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the bird-like figure. The text is in all capital letters and is evenly spaced around the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Ms. Michelle Schiltz-Taing Regulatorv Affairs Coordinator Bisco, Incorporated 1100 West Irving Park Road Schaumburg, Illinois 60193
MAY 2 5 2011
Re: K103514
Trade/Device Name: Pro-V Coat Regulation Number: 21 CFR 872.3770 Regulation Name: Temporary Crown and Bridge Resin Regulatory Class: II Product Code: EBG Dated: May 18, 2011 Received: May 20, 2011
Dear Ms. Schiltz-Taing:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2- Ms. Schiltz-Taing
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
hh for
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and . Radiological Health
Enclosure
{4}------------------------------------------------
| <strong>Labels</strong> | <strong>Values</strong> |
|----------------------------|-------------------------|
| 510 (k) Number (if known): | K10 3514 |
| Device Name: | Pro-V Coat |
Pro-V Coat is indicated for use as a separating agent when placed between any resin based material and to the substrate to which permanent bonding is not desired, such as:
- 1. any resin based material to the adhesive layer.
- 2. any resin based material to the remaining tooth structure.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Sueen Junne
(Division Sign-Off) (Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K103574